Court Place Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$513K Sell
3,660
-580
-14% -$78.4K 0.15% 97
2025
Q2
$533K Sell
4,240
-130
-3% -$16.2K 0.17% 91
2025
Q1
$598K Sell
4,370
-1,318
-23% -$188K 0.2% 84
2024
Q4
$870K Sell
5,688
-2,913
-34% -$491K 0.28% 70
2024
Q3
$1.67M Sell
8,601
-572
-6% -$120K 0.49% 49
2024
Q2
$2.13M Sell
9,173
-15
-0.2% -$3.26K 0.67% 43
2024
Q1
$1.98M Sell
9,188
-1,285
-12% -$301K 0.64% 42
2023
Q4
$2.71M Sell
10,473
-163
-2% -$40K 0.89% 29
2023
Q3
$2.73M Sell
10,636
-110
-1% -$29.4K 0.97% 25
2023
Q2
$3.06M Sell
10,746
-360
-3% -$107K 1.07% 22
2023
Q1
$3.09M Sell
11,106
-470
-4% -$130K 1.12% 23
2022
Q4
$3.21M Sell
11,576
-45
-0.4% -$12.7K 1.16% 24
2022
Q3
$3.1M Sell
11,621
-303
-3% -$64.4K 1.25% 21
2022
Q2
$2.43M Sell
11,924
-75
-0.6% -$15.3K 0.92% 29
2022
Q1
$2.53M Sell
11,999
-1,430
-11% -$311K 0.82% 30
2021
Q4
$3.22M Sell
13,429
-1,413
-10% -$363K 0.89% 28
2021
Q3
$4.2M Sell
14,842
-20
-0.1% -$6.55K 1.24% 19
2021
Q2
$5.15M Sell
14,862
-30
-0.2% -$9.09K 1.5% 16
2021
Q1
$4.17M Sell
14,892
-210
-1% -$56.6K 1.29% 17
2020
Q4
$3.7M Sell
15,102
-300
-2% -$77.4K 1.24% 19
2020
Q3
$4.37M Sell
15,402
-60
-0.4% -$16.7K 1.63% 16
2020
Q2
$4.14M Sell
15,462
-40
-0.3% -$12K 1.61% 16
2020
Q1
$4.91M Sell
15,502
-125
-0.8% -$37.9K 2.2% 10
2019
Q4
$4.64M Buy
15,627
+277
+2% +$76.9K 1.67% 15
2019
Q3
$3.57M Sell
15,350
-429
-3% -$99.9K 1.39% 18
2019
Q2
$3.69M Buy
15,779
+95
+0.6% +$21.9K 1.45% 18
2019
Q1
$3.71M Buy
15,684
+540
+4% +$170K 1.5% 16
2018
Q4
$4.56M Buy
15,144
+596
+4% +$190K 2.08% 9
2018
Q3
$5.14M Hold
14,548
1.95% 11
2018
Q2
$4.22M Sell
14,548
-210
-1% -$59K 1.75% 15
2018
Q1
$4.04M Buy
14,758
+630
+4% +$196K 1.69% 16
2017
Q4
$4.5M Sell
14,128
-40
-0.3% -$12.8K 1.86% 13
2017
Q3
$4.44M Sell
14,168
-60
-0.4% -$17.8K 1.98% 13
2017
Q2
$3.86M Sell
14,228
-60
-0.4% -$15.9K 1.83% 13
2017
Q1
$3.91M Sell
14,288
-100
-0.7% -$28.3K 1.92% 14
2016
Q4
$4.08M Buy
14,388
+348
+2% +$103K 2.12% 12
2016
Q3
$4.39M Sell
14,040
-35
-0.2% -$10.4K 2.44% 11
2016
Q2
$3.4M Buy
14,075
+440
+3% +$116K 1.97% 14
2016
Q1
$3.55M Buy
13,635
+7,400
+119% +$1.95M 2.19% 13
2015
Q4
$1.91M Buy
6,235
+3,440
+123% +$988K 1.22% 26
2015
Q3
$816K Buy
2,795
+5
+0.2% +$1.65K 0.56% 47
2015
Q2
$1.13M Hold
2,790
0.72% 42
2015
Q1
$1.18M Hold
2,790
0.75% 41
2014
Q4
$947K Hold
2,790
0.61% 49
2014
Q3
$923K Hold
2,790
0.63% 46
2014
Q2
$880K Hold
2,790
0.61% 47
2014
Q1
$853K Hold
2,790
0.62% 47
2013
Q4
$780K Buy
+2,790
New +$722K 0.6% 48

Other funds holding BIIB

Court Place Advisors's BIIB Position: Q3 2025 in Review

Court Place Advisors reduced its Biogen (BIIB) stake by 14% in Q3 2025, selling an estimated $78.4K and leaving 3,660 shares worth $513K. The position accounts for 0.15% of the portfolio, ranked #97.

Court Place Advisors first reported a position in BIIB in Q4 2013 and has held it in 48 quarters since. The position peaked at $5.15M in Q2 2021. 906 funds tracked by Wall St. Rank hold BIIB as of Q3 2025.

  • Court Place Advisors held 3,660 shares of Biogen worth $513K as of Q3 2025.
  • Court Place Advisors sold 580 Biogen shares in Q3 2025, an estimated $78.4K.
  • Biogen made up 0.15% of Court Place Advisors's portfolio in Q3 2025, its #97 holding.
  • Court Place Advisors first reported a position in Biogen in Q4 2013 and has held it in 48 quarters since.
  • Court Place Advisors's Biogen position peaked at $5.15M in Q2 2021.
  • 906 funds tracked by Wall St. Rank held Biogen as of Q3 2025.

Based on Court Place Advisors's 13F filing for Q3 2025, filed 25 Nov 2025.